Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.55 - $59.88 $296,140 - $407,184
6,800 New
6,800 $331,000
Q1 2022

May 17, 2022

BUY
$31.02 - $48.18 $279,180 - $433,620
9,000 Added 29.51%
39,500 $1.44 Million
Q4 2021

Feb 15, 2022

BUY
$41.14 - $56.98 $1.05 Million - $1.46 Million
25,600 Added 522.45%
30,500 $1.42 Million
Q2 2021

Aug 16, 2021

BUY
$25.8 - $41.09 $126,420 - $201,341
4,900 New
4,900 $201,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.68B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.